Efficacy of recombinant activated factor VII (rFVIIa; NovoSeven(®)) in obstetrical haemorrhagic shock

類似資料

• Recombinant activated factor VII (rFVIIa-NovoSeven(®)-NovoNordisk) treatment of bleeding complications in intensive care unit
  著者:: Bonadona, A, 等
  出版事項: (2002)
• Efficacy of activated recombinant factor VII (rFVIIa; NovoSeven(®)) in cirrhotic patients with upper gastrointestinal bleeding: a randomised placebo-controlled double-blind multicenter trial
  著者:: Thabut, D, 等
  出版事項: (2004)
• Recombinant Activated Factor VII (rFVIIa) in the Management of Major Obstetric Haemorrhage: A Case Series and a Proposed Guideline for Use
  著者:: Bomken, Charlotte, 等
  出版事項: (2009)
• Newly diagnosed congenital factor VII deficiency and utilization of recombinant activated factor VII (NovoSeven(®))
  著者:: Bartosh, Nicole S, 等
  出版事項: (2013)
• Nebulised recombinant activated factor VII (rFVIIa) does not attenuate the haemorrhagic effects of blast lung injury
  著者:: Smith, Jason E, 等
  出版事項: (2019)